Solutions
in a Heartbeat

REQUEST MORE INFORMATION

*required field

Going to HFSA?

Visit us at Booth 514

Solutions
in a Heartbeat

Going to HFSA?

Visit us at Booth 514

Sleep apnea can drive heart failure risks through the roof1,2

*Results from the NHLBI’s Sleep Heart Health Study.
†Compared to HF patients with mild to no sleep apnea in a prospective, observational study, P=0.029.

Because sleep apnea is a serious cardiac threat,

Turn to WatchPAT® TurnKey Sleep apnea diagnosis and treatment in as little as 2 weeks
Exclusively for cardiology practices, WatchPAT® TurnKey is a complimentary program that manages sleep apnea care for your patients. With expert services at every turn along the clinical pathway, WatchPAT® TurnKey delivers prompt, high-quality, comprehensive care and support that you and your patients can depend on.

REQUEST MORE INFORMATION

*required field

Continuous patient compliance monitoring and support to ensure best-in-class outcomes
  • Designed to enhance the patient’s experience and promote treatment acceptance
  • Digital compliance dashboard available online so you can check on your patients’ status anytime you want
Helps make life easier for you, your staff and your patients

Avoids the headache of preauthorization, billing and reimbursement, with:

The Real-World Benefits of WatchPAT® Turnkey:

“Write the order and you’re done…I think that we’ve increased continuity, we’ve increased patient participation, we’ve increased patient interest about getting a diagnostic test they generally would have fought us against. Finally, the amount of information and data that we’re currently collecting is going to be a game-changer for the future of how we care for patients with sleep apnea.”

IM_APRIL_Landing-Page_CARDIO_vert_bar

Sanda A. Carey, PhD, MPH, CCRN, ANP-BC, FHFSA
Baylor Scott & White Center for Advanced Heart and Lung Disease

Want to know more?

Just complete the form below

*required field

Facebook
Twitter
LinkedIn

*On average.

Reference: 1. Jean-Louis G, Zizi F. Brown DB, et al. Obstructive sleep apnea and cardiovascular disease: evidence and underlying mechanisms. Minerva Pneumol. 2009;48(4):277–293. 2. Wang H, Parker JD, Newton GE, et al. Inuence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol. 2007;49:1625-1631.

Your information will be handled in accordance with our privacy policy.

This material is subject to a disclaimer available here.

When using the marks in our publications and this website, we used the appropriate ™, ℠, or ®. The ® symbol is used to indicate registrations in the U.S. and the territories listed in https://www.itamar-medical.com/terms-and-conditions/ and this should not mean that such trademarks are necessarily registered in other countries. For example, WatchPAT®  is a trademark of Itamar Medical Ltd., registered in the U.S. and the applicable territories listed in https://www.itamar-medical.com/terms-and-conditions/ only.

WatchPAT® and PAT® are trademarks of Itamar Medical Ltd. Copyright © 2021 by Itamar Medical Ltd. All rights reserved.